Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Tang Chiu

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Biomedicines|March 28, 2025
Risk Factors and Awareness of Bone Fragility in Inflammatory Bowel Disease in Taiwan: A Cross-Sectional StudyYao-Wei Kuo, Chia-Jung Kuo, Puo-Hsien Le, et al.
Frontiers in Medicine|October 18, 2023
Fecal microbiota transplantation for treatment of refractory or recurrent <i>Clostridioides difficile</i> infection in Taiwan: a cost-effectiveness analysisKai-Yen Lan, Puo-Hsien Le, Cheng-Tang Chiu, et al.
Gut Pathogens|December 21, 2025
Enteric opportunistic infections in patients with inflammatory bowel disease receiving biologic therapies: a retrospective cohort studyTing-Chieh Huang, Tony Kou, Chia-Jung Kuo, et al.
Helicobacter|January 10, 2017
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scaleBor-Shyang Sheu, Ming-Shiang Wu, Cheng-Tang Chiu, et al.
BMC Genomics|March 1, 2008
Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosisMing-Ling Chang, Chau-Ting Yeh, Jeng-Chang Chen, et al.
Helicobacter|August 31, 2018
The implementation of the consensus on the management of Helicobacter pylori and barriers to consensusHsiu-Chi Cheng, Jyh-Ming Liou, Jiing-Chyuan Luo, et al.
International Journal of Colorectal Disease|July 23, 2025
Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitisChing-Reigh Hsieh, Chyi-Liang Chen, Chia-Jung Kuo, et al.
Plos One|August 15, 2014
Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearanceMing-Ling Chang, Yung-Kuan Tsou, Tsung-Hui Hu, et al.
Journal of Neurogastroenterology and Motility|March 3, 2016
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific RegionKhean Lee Goh, Myung Gyu Choi, Ping I Hsu, et al.
BMC Gastroenterology|July 12, 2020
Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strainsChia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Biomedicines|March 28, 2025
Risk Factors and Awareness of Bone Fragility in Inflammatory Bowel Disease in Taiwan: A Cross-Sectional StudyYao-Wei Kuo, Chia-Jung Kuo, Puo-Hsien Le, et al.
Frontiers in Medicine|October 18, 2023
Fecal microbiota transplantation for treatment of refractory or recurrent <i>Clostridioides difficile</i> infection in Taiwan: a cost-effectiveness analysisKai-Yen Lan, Puo-Hsien Le, Cheng-Tang Chiu, et al.
Gut Pathogens|December 21, 2025
Enteric opportunistic infections in patients with inflammatory bowel disease receiving biologic therapies: a retrospective cohort studyTing-Chieh Huang, Tony Kou, Chia-Jung Kuo, et al.
Helicobacter|January 10, 2017
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scaleBor-Shyang Sheu, Ming-Shiang Wu, Cheng-Tang Chiu, et al.
BMC Genomics|March 1, 2008
Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosisMing-Ling Chang, Chau-Ting Yeh, Jeng-Chang Chen, et al.
Helicobacter|August 31, 2018
The implementation of the consensus on the management of Helicobacter pylori and barriers to consensusHsiu-Chi Cheng, Jyh-Ming Liou, Jiing-Chyuan Luo, et al.
International Journal of Colorectal Disease|July 23, 2025
Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitisChing-Reigh Hsieh, Chyi-Liang Chen, Chia-Jung Kuo, et al.
Plos One|August 15, 2014
Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearanceMing-Ling Chang, Yung-Kuan Tsou, Tsung-Hui Hu, et al.
Journal of Neurogastroenterology and Motility|March 3, 2016
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific RegionKhean Lee Goh, Myung Gyu Choi, Ping I Hsu, et al.
BMC Gastroenterology|July 12, 2020
Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strainsChia-Jung Kuo, Cheng-Yu Lin, Puo-Hsien Le, et al.
Pageof 17